Targeting LGR5 + cells with an antibody-drug conjugate for the treatment of colon cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting LGR5
+
cells with an antibody-drug conjugate for the treatment of colon cancer
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 7, Issue 314, Pages 314ra186-314ra186
Publisher
American Association for the Advancement of Science (AAAS)
Online
2015-11-19
DOI
10.1126/scitranslmed.aac7433
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lgr5 marks stem/progenitor cells in ovary and tubal epithelia
- (2014) Annie Ng et al. NATURE CELL BIOLOGY
- Lymph node-independent liver metastasis in a model of metastatic colorectal cancer
- (2014) Ida B. Enquist et al. Nature Communications
- Lgr5+ Stem Cells Are Indispensable for Radiation-Induced Intestinal Regeneration
- (2013) Ciara Metcalfe et al. Cell Stem Cell
- DCDT2980S, an Anti-CD22-Monomethyl Auristatin E Antibody-Drug Conjugate, Is a Potential Treatment for Non-Hodgkin Lymphoma
- (2013) D. Li et al. MOLECULAR CANCER THERAPEUTICS
- In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration
- (2013) Meritxell Huch et al. NATURE
- Maturing antibody–drug conjugate pipeline hits 30
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- The Lgr5 intestinal stem cell signature: robust expression of proposed quiescent ‘+4’ cell markers
- (2012) Javier Muñoz et al. EMBO JOURNAL
- In situ validation of an intestinal stem cell signature in colorectal cancer
- (2012) Jennifer L Ziskin et al. GUT
- Fourth World Antibody-Drug Conjugate Summit
- (2012) Alain Beck et al. mAbs
- The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma
- (2012) Peter D Senter et al. NATURE BIOTECHNOLOGY
- Dclk1 distinguishes between tumor and normal stem cells in the intestine
- (2012) Yuki Nakanishi et al. NATURE GENETICS
- Lineage Tracing Reveals Lgr5+ Stem Cell Activity in Mouse Intestinal Adenomas
- (2012) A. G. Schepers et al. SCIENCE
- A reserve stem cell population in small intestine renders Lgr5-positive cells dispensable
- (2011) Hua Tian et al. NATURE
- Maytansinoid-Antibody Conjugates Induce Mitotic Arrest by Suppressing Microtubule Dynamic Instability
- (2010) E. Oroudjev et al. MOLECULAR CANCER THERAPEUTICS
- Wnt Signaling, Lgr5, and Stem Cells in the Intestine and Skin
- (2009) Andrea Haegebarth et al. AMERICAN JOURNAL OF PATHOLOGY
- Antibody-Drug Conjugates for the Treatment of Non-Hodgkin's Lymphoma: Target and Linker-Drug Selection
- (2009) A. G. Polson et al. CANCER RESEARCH
- In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes
- (2008) Luigi Quintieri et al. BIOCHEMICAL PHARMACOLOGY
- Crypt stem cells as the cells-of-origin of intestinal cancer
- (2008) Nick Barker et al. NATURE
- Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
- (2008) Jagath R Junutula et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started